Denali Therapeutics Inc. (DNLI) › Net IncomeDenali Therapeutics Inc. (DNLI) — Net IncomeAnnual figures by fiscal year, from SEC filings.2016: -$86.65M2017: -$88.19M2018: -$36.24M2019: -$197.61M2020: $71.14M2021: -$290.58M2022: -$325.99M2023: -$145.22M2024: -$422.77M2025: -$512.54M-$512.54M2016Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$512.54M-21.2%2024-$422.77M-191.1%2023-$145.22M+55.5%2022-$325.99M-12.2%2021-$290.58M-508.5%2020$71.14M+136.0%2019-$197.61M-445.3%2018-$36.24M+58.9%2017-$88.19M-1.8%2016-$86.65M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share